Friday 6 November 2026 Export TRLV’s income statement to Excel — free account

Trulieve Cannabis Corp.

TRLV Healthcare Drug Manufacturers Specialty & Generic

Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.

Revenue: −20.1%
EPS: −2,391.1%
Free cash flow: +24.5%
Total debt: −37.0%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

11.07 0.53 −4.57%

Follow TRLV

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −5.6×
Dividend yield: —
F-score: 6/9
Altman Z: 0.98
Beneish M: −2.99
Dividend safety: n/a

Overview

Trulieve Cannabis Corp. (TRLV) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Trulieve Cannabis Corp. (TRLV) trades at a price to free cash flow of 11.8×. Over the past ten years it has ranged from 0.0× (September 2023) to 29.9× (April 2025); the current reading is higher than 82% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 16.3× and below the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TRLV/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Trulieve Cannabis Corp. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TRLV/metrics/price-to-free-cash-flow">Trulieve Cannabis Corp. (TRLV) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	8.0×	(2.82%)
FY2024	8.2×	23.81%
FY2023	6.6×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—

Period	Price to free cash flow	Change
Sep 2026	11.7×	12.22%
Jun 2026	10.4×	112.27%
Mar 2026	4.9×	(38.65%)
Dec 2025	8.0×	(28.87%)
19 more quarters	Free account

Against its own ten years

Low 0.0× High 29.9×

Ten-year median 5.5×

Current reading's percentile 82

Company	Price to free cash flow
ALVO Alvotech compare	n/m
RGC Regencell Bioscience Holdings Limited compare	n/m
HCM HUTCHMED (China) Limited Sponsored ADR compare	n/m
BCRX BioCryst Pharmaceuticals, Inc. compare	5.3×
ANIP ANI Pharmaceuticals, Inc. compare	7.3×
PBH Prestige Consumer Healthcare Inc. compare	9.9×
TRLV Trulieve Cannabis Corp.	11.8×
PRGO Perrigo Company plc compare	12.4×
XERS Xeris Biopharma Holdings, Inc. compare	32.2×
Drug Manufacturers Specialty & Generic industry median	16.3×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Trulieve Cannabis Corp. (TRLV) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on TRLV

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on TRLV

Stockrow Weekly